Memphis Pharmaceuticals & Chemical Industries (EGX: MPCI)

Market Cap	324.06M
Revenue (ttm)	1.09B
Net Income (ttm)	307.55M
Shares Out	5.63M
EPS (ttm)	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	4.00 (6.94%)
Ex-Dividend Date	Nov 13, 2024

Volume	28,700
Open	57.60
Previous Close	57.60
Day's Range	57.40 - 58.70
52-Week Range	31.00 - 139.99
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 14, 2024

About MPCI

Memphis Pharmaceuticals & Chemical Industries, a drug holding company, produces and sells pharmaceutical products for human and veterinary use in Egypt and internationally. The company offers human health products in various therapeutic areas, including anti-infective, CNS, dermatological, cardio vascular system, corticosteroid, vitamins and minerals, musculo-skeletal system, analgesic and antipyretic, respiratory system, genitourinary system, alimentary tract and metabolism, antihistaminic, antiparasites, and hormones. It also provides animal ...

• Industry: Pharmaceutical Preparations
• Founded: 1940
• Employees: 144
• Stock Exchange: Egyptian Stock Exchange
• Ticker Symbol: MPCI

Financial Performance

In 2024, MPCI's revenue was 871.91 million, an increase of 31.34% compared to the previous year's 663.83 million. Earnings were 191.46 million, an increase of 111.70%.